Kedar Janani Chemplast Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 09-12-2024
- Paid Up Capital ₹ 4.40 M
as on 09-12-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.82 Cr
as on 09-12-2024
- Satisfied Charges ₹ 4.00 M
as on 09-12-2024
- Revenue 182.96%
(FY 2022)
- Profit 810.41%
(FY 2022)
- Ebitda 460.83%
(FY 2022)
- Net Worth 155.53%
(FY 2022)
- Total Assets 10.50%
(FY 2022)
About Kedar Janani Chemplast
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.40 M.
The company currently has active open charges totaling ₹11.82 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pratik Patel, Pavan Patel, Hiten Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100MH1995PTC089908
- Company No.
089908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Kedar Janani Chemplast?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratik Patel  | Director | 15-Dec-2010 | Current |
| Pavan Patel | Director | 02-May-2011 | Current |
| Hiten Patel | Director | 23-Jun-1995 | Current |
| Nitaben Patel | Director | 01-Jan-2001 | Current |
Financial Performance of Kedar Janani Chemplast.
Kedar Janani Chemplast Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 182.96% increase. The company also saw a substantial improvement in profitability, with a 810.41% increase in profit. The company's net worth Soared by an impressive increase of 155.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kedar Janani Chemplast?
In 2022, Kedar Janani Chemplast had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vanquest Pharma Private LimitedActive 5 years 7 monthsPratik Patel, Pavan Patel and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jul 2019 | ₹3.00 Cr | Open |
Bank Of Baroda Creation Date: 30 Mar 2013 | ₹4.41 Cr | Open |
Bank Of Baroda Creation Date: 23 Feb 2013 | ₹4.41 Cr | Open |
How Many Employees Work at Kedar Janani Chemplast?
Unlock and access historical data on people associated with Kedar Janani Chemplast, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kedar Janani Chemplast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kedar Janani Chemplast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
